Immune system modulation
Cat's claw POAs demonstrate immunomodulatory effects — stimulating phagocytosis, NK cell activity, and lymphocyte proliferation in laboratory and preliminary human studies. Traditional use for recurrent infections and immune deficiency has some mechanistic support, though large clinical trials are lacking.
Rheumatoid arthritis symptom reduction
A small but well-designed RCT (Phase II) showed freeze-dried cat's claw extract significantly reduced swollen joint count and patient-assessed pain vs. placebo in RA patients on standard therapy — with 53% reduction in swollen joints vs. 24% placebo. Larger confirmatory trials needed.
Anti-inflammatory and antioxidant activity
Cat's claw inhibits TNF-α production, NF-κB activation, and COX-2 expression in laboratory studies, and demonstrates antioxidant activity through direct free radical scavenging. These mechanisms support the traditional anti-inflammatory applications in arthritis and infection.
DNA repair support
AC-11® (a water-soluble cat's claw extract) has demonstrated DNA repair-enhancing activity in human cell studies — increasing nucleotide excision repair of UV-induced DNA damage. This novel mechanism has attracted interest for anti-aging and cancer prevention applications.
POA immunostimulation vs. TOA immunosuppression
Pentacyclic oxindole alkaloids (POAs) stimulate immune function via macrophage activation and lymphocyte proliferation. Tetracyclic oxindole alkaloids (TOAs) competitively antagonize POA immune-stimulating activity. High-quality POA-standardized extracts (with minimal TOAs) are required for consistent immune benefits — explains the inconsistent results seen with non-standardized products.
NF-κB and TNF-α inhibition
Cat's claw alkaloids and quinovic acid glycosides inhibit NF-κB nuclear translocation and reduce TNF-α production in macrophages and synovial cells — providing the anti-inflammatory mechanism relevant to rheumatoid arthritis and inflammatory conditions.
Nucleotide excision repair pathway enhancement
AC-11® extract enhances the cellular nucleotide excision repair (NER) pathway that removes UV-induced and chemically-damaged DNA bases. This DNA repair mechanism is being studied for applications in cancer chemoprevention and UV skin protection.
Randomized, double-blind, placebo-controlled phase II trial of freeze-dried cat's claw extract (60 mg/day) vs. placebo in 40 RA patients on stable medication for 24 weeks.
40 RA patients on stable DMARD therapy. 24-week add-on trial.
Cat's claw significantly reduced swollen joint count vs. placebo (53% vs. 24% reduction). Patient-assessed pain improved. Tender joint count and disease activity scores trended toward improvement. Well-tolerated. Larger trial warranted.